# Liraglutide

NDC: 0143-9144
Generic name: liraglutide
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20241224

FDA application: ANDA215503

## Active ingredients

- LIRAGLUTIDE: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9144"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9144
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2100ec49-57b2-4330-ab5f-057ce9b7e4d0